• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种自主研发的用于晚期宫颈癌间质加腔内高剂量率图像引导近距离放疗的阴道内模板的调试及剂量学结果

Commissioning and Dosimetric Results of an Indigenously Developed Intra-Vaginal Template for Interstitial Plus Intracavitary High dose Rate Image-Guided Brachytherapy of Advanced Cervix Cancer.

作者信息

Kaliyaperumal Venkatesan, Banerjee Susovan, Kataria Tejinder, Abraham Susan K, Kamaraj Dayanithi, Tamilselvan Singaravelu, Gupta Deepak, Bisht Shyam Singh, Narang Kushal, Shishak Sorun

机构信息

Division of Radiation Oncology, Medanta Cancer Institute, Medanta the Medicity, Gurgaon, Haryana, India.

出版信息

J Med Phys. 2022 Oct-Dec;47(4):322-330. doi: 10.4103/jmp.jmp_50_22. Epub 2023 Jan 10.

DOI:10.4103/jmp.jmp_50_22
PMID:36908497
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9997539/
Abstract

AIM

The goal of this study is to discuss the commissioning and dosimetric parameters achieved during the clinical implementation of an indigenously developed intracavitary (IC) plus interstitial (IS) template for high dose rate (HDR) image-guided brachytherapy (IGBT) in cancer (Ca) cervix. We want to discuss our achieved values of cumulative equi-effective doses (EQD2) for high-risk clinical target volume (HRCTV) and organ at risk (OAR) and compare it with available published results.

MATERIALS AND METHODS

Medanta anterior oblique/lateral oblique template has a total of 19 needles including the central tandem. For commissioning the template with needles, the indigenously made acrylic phantom was used. Oblique and straight needles were placed inside the acrylic phantom and a computed tomography (CT) scan was performed. Sixteen patients were treated in HDR IGBT using this template after external-beam radiotherapy. The IGBT plans were evaluated based on EQD2 of target coverage i.e., dose received by 98% (D_HRCTV), 90% (D_HRCTV), and 50% (D_HRCTV) volume of HRCTV, and dose received by 2 cc (D) and 0.1 cc (D) of OAR using linear quadratic (LQ) radiobiological model.

RESULTS

The autoradiographic in radiochromic film shows that the distance between the needle tip and the middle of the source position is 6 mm. The mean D98%_HRCTV and D90%_HRCTV was 76.8 Gy (range: 70-87.7 Gy, < 0.01) and 84.49 Gy (range: 76.6-96.7 Gy, < 0.01), respectively. Mean EQD2 of D2cc of the bladder, rectum, and sigmoid was 85.6 Gy (range: 77.5-99.6 Gy, < 0.03), 74.3 Gy (range: 70.9-76.7 Gy, < 0.05), and 58.3 Gy (range: 50.6-67.9 Gy, = 0.01), respectively. The mean total reference air kerma at a 1 m distance is 0.489cGy (range: 0.391-0.681cGy).

CONCLUSIONS

The indigenously developed template could attain satisfactory standards in terms of set parameters for commissioning and acceptable dose volume relations in our clinical use for treating the advanced Ca cervix patients who need IC + IS type of HDR IGBT. The comparative analysis with contemporary applicators was acceptable.

摘要

目的

本研究的目的是探讨在临床应用国产腔内(IC)加组织间(IS)模板进行宫颈癌高剂量率(HDR)图像引导近距离放疗(IGBT)过程中所实现的调试和剂量学参数。我们希望讨论高危临床靶区(HRCTV)和危及器官(OAR)的累积等效有效剂量(EQD2)的实现值,并将其与已发表的结果进行比较。

材料与方法

Medanta前后斜位/侧斜位模板共有19根针,包括中央串联针。为了用针调试模板,使用了国产丙烯酸模体。将斜针和直针放置在丙烯酸模体内并进行计算机断层扫描(CT)。16例患者在体外放疗后使用该模板进行HDR IGBT治疗。基于靶区覆盖的EQD2评估IGBT计划,即HRCTV的98%(D_HRCTV)、90%(D_HRCTV)和50%(D_HRCTV)体积所接受的剂量,以及使用线性二次(LQ)放射生物学模型评估OAR的2 cc(D)和0.1 cc(D)所接受的剂量。

结果

放射变色胶片的放射自显影片显示针尖与源位置中点之间的距离为6 mm。HRCTV的平均D98%和D90%分别为76.8 Gy(范围:70 - 87.7 Gy,<0.01)和84.49 Gy(范围:76.6 - 96.7 Gy,<0.01)。膀胱、直肠和乙状结肠的D2cc的平均EQD2分别为85.6 Gy(范围:77.5 - 99.6 Gy,<0.03)、74.3 Gy(范围:70.9 - 76.7 Gy,<0.05)和58.3 Gy(范围:50.6 - 67.9 Gy,=0.01)。在1 m距离处的平均总参考空气比释动能为0.489 cGy(范围:0.391 - 0.681 cGy)。

结论

在我们临床用于治疗需要IC + IS型HDR IGBT的晚期宫颈癌患者时,国产模板在调试设置参数和可接受的剂量体积关系方面能够达到令人满意的标准。与当代施源器的比较分析是可以接受的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20c6/9997539/808202758935/JMP-47-322-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20c6/9997539/aac2220facfd/JMP-47-322-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20c6/9997539/f742981fc420/JMP-47-322-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20c6/9997539/d4b857c20f2d/JMP-47-322-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20c6/9997539/bd47e9770cd3/JMP-47-322-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20c6/9997539/1e93d588f4a5/JMP-47-322-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20c6/9997539/f83f7ddf22ca/JMP-47-322-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20c6/9997539/808202758935/JMP-47-322-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20c6/9997539/aac2220facfd/JMP-47-322-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20c6/9997539/f742981fc420/JMP-47-322-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20c6/9997539/d4b857c20f2d/JMP-47-322-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20c6/9997539/bd47e9770cd3/JMP-47-322-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20c6/9997539/1e93d588f4a5/JMP-47-322-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20c6/9997539/f83f7ddf22ca/JMP-47-322-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20c6/9997539/808202758935/JMP-47-322-g007.jpg

相似文献

1
Commissioning and Dosimetric Results of an Indigenously Developed Intra-Vaginal Template for Interstitial Plus Intracavitary High dose Rate Image-Guided Brachytherapy of Advanced Cervix Cancer.一种自主研发的用于晚期宫颈癌间质加腔内高剂量率图像引导近距离放疗的阴道内模板的调试及剂量学结果
J Med Phys. 2022 Oct-Dec;47(4):322-330. doi: 10.4103/jmp.jmp_50_22. Epub 2023 Jan 10.
2
Dosimetric analysis of 3D image-guided HDR brachytherapy planning for the treatment of cervical cancer: is point A-based dose prescription still valid in image-guided brachytherapy?3D图像引导的高剂量率近距离放射治疗计划用于宫颈癌治疗的剂量学分析:在图像引导的近距离放射治疗中,基于A点的剂量处方是否仍然有效?
Med Dosim. 2011 Summer;36(2):166-70. doi: 10.1016/j.meddos.2010.02.009. Epub 2010 May 21.
3
Dosimetric comparison of Co and Ir high dose rate source used in brachytherapy treatment of cervical cancer.用于宫颈癌近距离放射治疗的钴源和铱源高剂量率的剂量学比较。
J Cancer Res Ther. 2019 Oct-Dec;15(6):1212-1215. doi: 10.4103/jcrt.JCRT_372_19.
4
Image guided radiation therapy boost in combination with high-dose-rate intracavitary brachytherapy for the treatment of cervical cancer.影像引导放射治疗加量联合高剂量率腔内近距离放射治疗用于宫颈癌的治疗
J Contemp Brachytherapy. 2016 Apr;8(2):122-7. doi: 10.5114/jcb.2016.59282. Epub 2016 Apr 14.
5
Intra-fractional dosimetric analysis of image-guided intracavitary brachytherapy of cervical cancer.图像引导腔内近距离治疗宫颈癌的分次内剂量分析。
Radiat Oncol. 2021 Aug 4;16(1):144. doi: 10.1186/s13014-021-01870-x.
6
Radiobiological optimization comparison between pulse-dose-rate and high-dose-rate brachytherapy in patients with locally advanced cervical cancer.局部晚期宫颈癌患者中脉冲剂量率与高剂量率近距离放疗的放射生物学优化比较
Brachytherapy. 2019 May-Jun;18(3):370-377. doi: 10.1016/j.brachy.2018.12.009. Epub 2019 Feb 21.
7
Dosimetric study for cervix carcinoma treatment using intensity modulated radiation therapy (IMRT) compensation based on 3D intracavitary brachytherapy technique.基于三维腔内近距离放射治疗技术的调强放射治疗(IMRT)补偿用于宫颈癌治疗的剂量学研究
J Contemp Brachytherapy. 2016 Jun;8(3):221-32. doi: 10.5114/jcb.2016.60590. Epub 2016 Jun 14.
8
Deformable image registration-based contour propagation yields clinically acceptable plans for MRI-based cervical cancer brachytherapy planning.基于可变形图像配准的轮廓传播可为基于磁共振成像的宫颈癌近距离治疗计划生成临床可接受的方案。
Brachytherapy. 2018 Mar-Apr;17(2):360-367. doi: 10.1016/j.brachy.2017.11.019. Epub 2018 Jan 10.
9
Dose-volume histogram parameters and local tumor control in magnetic resonance image-guided cervical cancer brachytherapy.磁共振图像引导下宫颈癌近距离放疗中的剂量体积直方图参数与局部肿瘤控制
Int J Radiat Oncol Biol Phys. 2009 Sep 1;75(1):56-63. doi: 10.1016/j.ijrobp.2008.10.033. Epub 2009 Mar 14.
10
Trans-rectal ultrasound-guided hybrid intra-cavitary and interstitial brachytherapy in carcinoma cervix: A feasibility study from a tertiary cancer center in India.经直肠超声引导下腔内与组织间混合近距离放射治疗宫颈癌:来自印度一家三级癌症中心的可行性研究
J Contemp Brachytherapy. 2023 Jun;15(3):198-205. doi: 10.5114/jcb.2023.127816. Epub 2023 May 31.

本文引用的文献

1
Evolution of Brachytherapy Applicators for the Treatment of Cervical Cancer.宫颈癌近距离放射治疗施源器的发展历程
J Med Phys. 2021 Oct-Dec;46(4):231-243. doi: 10.4103/jmp.jmp_62_21. Epub 2021 Dec 31.
2
Practical needle selection for Vienna-style applicators: improving therapeutic ratio in hybrid intracavitary-interstitial brachytherapy.维也纳式施源器的实用针具选择:提高腔内-组织间混合近距离放射治疗的治疗比
J Contemp Brachytherapy. 2021 Oct;13(5):533-540. doi: 10.5114/jcb.2021.110348. Epub 2021 Oct 29.
3
A comparison of tandem ring and tandem ovoid treatment as a curative brachytherapy component for cervical cancer.
串联环与串联卵形治疗作为宫颈癌根治性近距离放疗组成部分的比较。
J Contemp Brachytherapy. 2020 Apr;12(2):111-117. doi: 10.5114/jcb.2020.94308. Epub 2020 Apr 8.
4
The Medanta AOLO template for locally advanced cancer cervix brachytherapy: design and clinical implementation.用于局部晚期宫颈癌近距离放疗的麦丹塔AOLO模板:设计与临床应用
J Contemp Brachytherapy. 2020 Feb;12(1):44-47. doi: 10.5114/jcb.2020.92528. Epub 2020 Feb 28.
5
Ring Versus Ovoids and Intracavitary Versus Intracavitary-Interstitial Applicators in Cervical Cancer Brachytherapy: Results From the EMBRACE I Study.宫颈癌近距离放疗中环形与椭圆形施源器、腔内与腔内-间质施源器的比较:EMBRACE I 研究结果。
Int J Radiat Oncol Biol Phys. 2020 Apr 1;106(5):1052-1062. doi: 10.1016/j.ijrobp.2019.12.019. Epub 2020 Jan 30.
6
Indian Brachytherapy Society Guidelines for radiotherapeutic management of cervical cancer with special emphasis on high-dose-rate brachytherapy.印度近距离放疗协会宫颈癌放射治疗管理指南,特别强调高剂量率近距离放疗。
J Contemp Brachytherapy. 2019 Aug;11(4):293-306. doi: 10.5114/jcb.2019.87406. Epub 2019 Aug 29.
7
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.全球癌症统计数据 2018:GLOBOCAN 对全球 185 个国家/地区 36 种癌症的发病率和死亡率的估计。
CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12.
8
Combined intracavitary and interstitial brachytherapy of cervical cancer using the novel hybrid applicator Venezia: Clinical feasibility and initial results.使用新型混合施源器Venezia对宫颈癌进行腔内和组织间联合近距离放射治疗:临床可行性及初步结果
Brachytherapy. 2018 Sep-Oct;17(5):775-781. doi: 10.1016/j.brachy.2018.05.009. Epub 2018 Jun 22.
9
The EMBRACE II study: The outcome and prospect of two decades of evolution within the GEC-ESTRO GYN working group and the EMBRACE studies.EMBRACE II研究:GEC-ESTRO妇科工作组及EMBRACE研究二十年发展的成果与展望
Clin Transl Radiat Oncol. 2018 Jan 11;9:48-60. doi: 10.1016/j.ctro.2018.01.001. eCollection 2018 Feb.
10
Use of ultrasound in image-guided high-dose-rate brachytherapy: enumerations and arguments.超声在图像引导高剂量率近距离放射治疗中的应用:列举与论证。
J Contemp Brachytherapy. 2017 Apr;9(2):146-150. doi: 10.5114/jcb.2017.67456. Epub 2017 Apr 27.